This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Revaax Pharmaceuticals, LLC, Eli Lilly and Company. Active years: 1998-2010.
Company Filing History:
Years Active: 1998-2010
Title: Michael O Chaney: Innovator in Neurotherapeutics
Introduction
Michael O Chaney is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of neurotherapeutics, holding a total of 3 patents. His work focuses on innovative treatments for neurological disorders, showcasing his dedication to advancing medical science.
Latest Patents
Among his latest patents is the development of oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions. This patent describes the treatment of neurological disorders using these compositions, which include pharmaceutical formulations with oral dosage forms. Another significant patent involves the neurotherapeutic use of carboxypeptidase inhibitors. This invention highlights the administration of inhibitors that provide neurotropic effects, evidenced by improvements in behavior and cognition in warm-blooded vertebrates. Additionally, certain β-lactam antibiotics, particularly specific 1-oxa-1-dethia cephems, have been identified for their potent therapeutic neurologic activity.
Career Highlights
Michael has worked with prominent companies in the pharmaceutical industry, including Revaax Pharmaceuticals, LLC and Eli Lilly and Company. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues such as Gary A Koppel and Robert F Bruns, Jr. These partnerships have further enriched his research and development efforts in neurotherapeutics.
Conclusion
Michael O Chaney stands out as a pioneering inventor in the field of neurotherapeutics. His innovative patents and collaborations reflect his commitment to improving treatments for neurological disorders. His contributions continue to influence the landscape of medical science.